Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

What is chronic inflammatory demyelinating polyneuropathy?

CIDP is a rare neuropathy where damage to peripheral nerves may cause progressive weakness and a loss of feeling, typically in the arms and legs, that can impair a patient's ability to walk and complete activities of daily living.

CIDP is believed to be caused by an immune response, in some cases with IgG antibodies, that can damage nerve function resulting in slower transmission of nerve signals out to the body and up to the brain.

CIDP may be intermittent or slowly progressive. CIDP typically causes symmetrical (both sides of body) weakness and loss of sensation, which can result in loss of balance, tingling and weakness in arms and legs, and impairment of ability to walk and be independent in activities of daily living.

CIDP patients often experience fatigue and pain.

Clinical Trials

For more info on clinical trials for chronic inflammatory demyelinating
polyneuropathy, please click the link below.


For more information on this disease, please find here additional resources and links to advocacy organizations.

GBS-CIDP Foundation International

The GBS-CIDP Foundation’s mission is to improve the quality of life for individuals and families affected by GBS, CIDP, and related conditions.

International Patient Organisation for Primary Immunodeficiencies